Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Farida Arjuman

Farida Arjuman

National Institute of Cancer Research & Hospital, Bangladesh

Title: Intraoral buccal mass as the manifestation of testicular choriocarcinoma – A Case report

Biography

Biography: Farida Arjuman

Abstract

Metastatic tumors to the oral cavity are extremely rare lesions that represent 1% of all oral and maxillofacial malignancies. It is invariably associated with a widespread disease and a poor prognosis. Such metastasis occurs mostly in the jaw bones than the soft tissues of the mouth. Metastasis to the oral soft tissues most prevalently affects the gingiva and alveolar mucosa. We present an unusual case of a testicular choriocarcinoma metastasized to the buccal mucosa mimicking a reactive lesion. An 18 year old male patient presented with a right sided intraoral buccal mass for one month in the department of oral & maxillofacial surgery department of NICRH. Intraoral physical examination detected a nodular tumor, sessile and bleeds when manipulated. Clinically it was diagnosed as pyogenic granuloma. In addition there was right sided non-tender testicular swelling which he noticed eight months earlier. His beta HCG level was 225000 mIU/ml and alfa Fetoprotein level was 2.23ng/ml. Ultrasonography shows right testicular mass, para-aortic lymphadenopathy and multiple hepatic SOL. CT scan shows soft tissue mass in the right hemimandible area. Excision of the right sided intraoral buccal mass and right sided hemimandibulectomy was done. Histopathological examination reveals testicular choriocarcinoma. The primary lesion must be removed by orchiectomy. In patients with metastatic illness, the disease must be controlled with cytotoxic chemotherapy, which results in complete regression of the metastasis in 60% to 90% of patients